Adma Biologics (ADMA) EBIT Margin Growth (3y) (2016 - 2025)
Adma Biologics (ADMA) EBIT Margin Growth (3y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Adma Biologics |
1.98 Bn |
1.89 Bn |
88.82 Mn |
5,721.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
5,721.00 |
| Sep 30, 2025 |
6,068.00 |
| Jun 30, 2025 |
4,732.00 |
| Mar 31, 2025 |
8,129.00 |
| Dec 31, 2024 |
5,659.00 |
| Sep 30, 2024 |
10,289.00 |
| Jun 30, 2024 |
12,396.00 |
| Mar 31, 2024 |
12,114.00 |
| Dec 31, 2023 |
14,265.00 |
| Sep 30, 2023 |
14,219.00 |
| Jun 30, 2023 |
21,910.00 |
| Mar 31, 2023 |
16,299.00 |
| Dec 31, 2022 |
5,290.00 |
| Sep 30, 2022 |
10,263.00 |
| Jun 30, 2022 |
14,975.00 |
| Mar 31, 2022 |
32,342.00 |
| Dec 31, 2021 |
38,395.00 |
| Sep 30, 2021 |
25,620.00 |
| Jun 30, 2021 |
20,076.00 |
| Mar 31, 2021 |
31,453.00 |
